There's no trodden path here. We can't go back and look at what other companies have done because no other company has done this.

People can still smoke but they won't get any benefit from it. So, why would they want to?

The nicotine molecule is too small to affect an immune response. By soaking it up, our carrier protein creates a molecule that is too big to break the blood-brain barrier.

We believe this is the first Fast Track Designation for a smoking cessation product candidate, which is unprecedented, and provides further validation for our unique approach to addressing nicotine addiction.

When an elephant raids a crop field, it can be devastating for a farmer. Sometimes the elephants are spotted and shot in the act.